Istios Health LLC

Istios Health LLC, based in the US, is a healthcare company that enhances infectious disease management through specialized clinical services and innovative solutions for healthcare providers and life sciences organizations. Istios Health LLC specializes in improving infectious disease care by providing tailored solutions to healthcare facilities and providers. The company was founded in Phoenix, US, and has received funding through a Seed round led by BIP Ventures, raising USD 5. 6 mn.

The latest funding round, dated June 23, 2025, represents the total amount raised. The founder's history and previous ventures are not available at this time. Istios Health specializes in advancing infectious disease care through a comprehensive suite of solutions tailored for healthcare facilities, providers, and the life sciences industry. The company's core offerings include virtual inpatient and outpatient specialist coverage, peer-to-peer support, and robust infection prevention and control program support, all designed to enhance clinical workflows and improve patient outcomes.

These services are particularly beneficial for healthcare providers looking to expand their scope of practice and utilize quality reporting and benchmarking tools. Additionally, Istios Health has established a national network of highly-specialized clinical trial sites, powered by a real-world evidence platform that accelerates patient recruitment and enhances trial quality. The company's services are primarily offered in the United States, serving a broad client base that includes hospitals, healthcare systems, and life science organizations. Istios Health generates revenue through a model that emphasizes service subscriptions and partnerships within the healthcare sector.

Clients, such as healthcare facilities and providers, engage with the company to access specialized clinical services and support programs. The transactional structure typically involves contractual agreements wherein clients subscribe to comprehensive service packages that encompass infection control programs and access to clinical trial networks. While specific pricing plans and flagship services have not been disclosed, the revenue model suggests that clients pay for tailored solutions based on their unique needs and the scale of services utilized. This structured approach allows Istios Health to maintain a steady revenue stream while delivering critical care advancements in the field of infectious disease.

In June 2025, Istios Health LLC raised USD 5. 6 mn in Seed funding led by new investor BIP Ventures, with participation from RVM Enterprises. The company plans to use the funding to accelerate its healthcare strategies and services. Future initiatives include the design and launch of new products aimed at enhancing infectious disease management.

Istios Health is also considering expansion into additional geographic regions to broaden its market presence.